VistaGen Therapeutics Inc
NASDAQ:VTGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
VistaGen Therapeutics Inc
NASDAQ:VTGN
|
US |
Intrinsic Value
The intrinsic value for VistaGen Therapeutics Inc (VTGN) under the Base Case is 1.6079 USD. Compared with the current market price of 0.2328 USD, the stock appears Undervalued by 86% .
Do our valuations actually work? See backtest results .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for VistaGen Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
VistaGen Therapeutics Inc
Earnings Waterfall
VistaGen Therapeutics Inc
The intrinsic value for VistaGen Therapeutics Inc (VTGN) under the Base Case is 1.6079 USD.
Compared with the current market price of 0.2328 USD, the stock appears Undervalued by 86% .